Russell Frank Company’s Agios Pharmaceuticals AGIO Stock Holding History

Russell Frank Company’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$70K	Sell	1,711 -1,814	-51%	-$77.6K	﹤0.01%	2824
2015 Q4	$229K	Hold	3,525	–	–	﹤0.01%	2675
2015 Q3	$249K	Buy	3,525 +430	+14%	+$42K	﹤0.01%	2656
2015 Q2	$345K	Buy	3,095 +1,618	+110%	+$174K	﹤0.01%	2684
2015 Q1	$139K	Sell	1,477 -8,968	-86%	-$1M	﹤0.01%	2705
2014 Q4	$1.17M	Sell	10,445 -8,848	-46%	-$790K	﹤0.01%	2059
2014 Q3	$1.18M	Sell	19,293 -8,129	-30%	-$350K	﹤0.01%	1984
2014 Q2	$1.11M	Buy	27,422 +6,465	+31%	+$264K	﹤0.01%	2014
2014 Q1	$820K	Buy	+20,957	New	+$701K	﹤0.01%	2174

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

FVF2

Flagship Ventures Fund 2007 Cambridge, Massachusetts $95.2M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Russell Frank Company's AGIO Position: Q1 2016 in Review

Russell Frank Company reduced its Agios Pharmaceuticals (AGIO) stake by 51% in Q1 2016, selling an estimated $77.6K and leaving 1,711 shares worth $70K. The position accounts for ﹤0.01% of the portfolio, ranked #2824.

Russell Frank Company first reported a position in AGIO in Q1 2014 and has held it in 9 quarters since. The position peaked at $1.18M in Q3 2014. 156 funds tracked by Wall St. Rank hold AGIO as of Q1 2016.

Russell Frank Company held 1,711 shares of Agios Pharmaceuticals worth $70K as of Q1 2016.
Russell Frank Company sold 1,814 Agios Pharmaceuticals shares in Q1 2016, an estimated $77.6K.
Agios Pharmaceuticals made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2824 holding.
Russell Frank Company first reported a position in Agios Pharmaceuticals in Q1 2014 and has held it in 9 quarters since.
Russell Frank Company's Agios Pharmaceuticals position peaked at $1.18M in Q3 2014.
156 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.